Table of contents

Extended reports

• Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders (11 August, 2006)

  T Ellingsen, N Hornung, B K Møller, J H Poulsen, K Stengaard-Pedersen
• Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: The Rotterdam Study (12 July, 2006) Free

  M Reijman, H A P Pols, A P Bergink, J M W Hazes, J N Belo, A M Lievense, S M A Bierma-Zeinstra
• Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial (17 October, 2006)

  D D Gladman, P J Mease, M A Cifaldi, R J Perdok, E Sasso, J Medich
• Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test (25 July, 2006)

  M H Buch, C P Denton, D E Furst, L Guillevin, L J Rubin, A U Wells, M Matucci-Cerinic, G Riemekasten, P Emery, H Chadha-Boreham, P Charef, S Roux, C M Black, J R Seibold
• Abdominal manifestations in childhood-onset systemic lupus erythematosus (3 July, 2006)

  O Richer, T Ulinski, I Lemelle, B Ranchin, C Loirat, J C Piette, P Pillet, P Quartier, R Salomon, B Bader-Meunier
• Perinatal and early childhood risk factors associated with rheumatoid factor positivity in a healthy paediatric population (22 January, 2007)

  Kendra A Young, Lezlie A Parrish, Gary O Zerbe, Marian Rewers, Kevin D Deane, V Michael Holers, Jill M Norris
• Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis (7 June, 2006)

  V P van Halm, M M J Nielen, M T Nurmohamed, D van Schaardenburg, H W Reesink, A E Voskuyl, J W R Twisk, R J van de Stadt, M H M T de Koning, M R Habibuw, I E van der Horst–Bruinsma, B A C Dijkmans
• Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment (19 September, 2006)

  A S Russell, G V Wallenstein, T Li, M C Martin, R Maclean, B Blaisdell, K Gajria, J C Cole, J-C Becker, P Emery
• Rheumatoid arthritis and genetic markers in Syrian and French populations: different effect of the shared epitope (26 October, 2006)

  Leyla Kazkaz, Hubert Marotte, Mayassa Hamwi, Marie Angélique Cazalis, Pascal Roy, Bruno Mougin, Pierre Miossec
• Haematopoietic stem cell transplantation for vasculitis including Behçet’s disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature (1 September, 2006)

  Thomas Daikeler, Ina Kötter, Chiara Bocelli Tyndall, Jane Apperley, Andishe Attarbaschi, Philippe Guardiola, Alois Gratwohl, Esa Jantunen, Alberto Marmont, Ferdinando Porretto, Maurizio Musso, Britta Maurer, Nadia Rinaldi, Riccardo Saccardi, Alan Tyndall
• High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors (10 August, 2006)

  Cecilia P Chung, Ingrid Avalos, Annette Oeser, Tebeb Gebretsadik, Ayumi Shintani, Paolo Raggi, C Michael Stein
• The cost effectiveness of behavioural graded activity in patients with osteoarthritis of hip and/or knee (31 July, 2006)

  Veerle M H Coupé, Cindy Veenhof, Maurits W van Tulder, Joost Dekker, Johannes W J Bijlsma, Cornelia H M Van den Ende
• Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies (10 August, 2006)

  Richard Watts, Suzanne Lane, Thomas Hanslik, Thomas Hauser, Bernhard Hellmich, Wenche Koldingsnes, Alfred Mahr, Mårten Segelmark, Jan W Cohen-Tervaert, David Scott
• Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial (25 August, 2006)

  Michael Weinblatt, Michael Schiff, Allan Goldman, Joel Kremer, Michael Luggen, Tracy Li, Dalei Chen, Jean-Claude Becker
• Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study (22 August, 2006)

  Hilary A Capell, Rajan Madhok, Duncan R Porter, Robin A L Munro, Iain B McInnes, John A Hunter, Malcolm Steven, Asad Zoma, Elaine Morrison, Martin Sambrook, Fat Wui Poon, Rosemary Hampson, Fiona McDonald, Ann Tierney, Neil Henderson, Ian Ford